预约演示

Twist and Cancer Research Horizons sign antibody library platform deal

2023-07-19

引进/卖出抗体药物偶联物

The library of libraries is a collection of synthesised antibody libraries. Credit: angellodeco / Shutterstock.com.

Twist Bioscience and Cancer Research UK’s innovation arm Cancer Research Horizons have signed an agreement to license a “library of libraries”.

Twist Bioscience librCancer Research Cancer libraries will be licensed byCancer Research Horizons Cancerr Research Horizons for a five-year period.

Twistmended ReportsCancer

ReportsBromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) Drugs... GlobalData

ReportsLOA and PTSR Model - Vilamakitug in Pancreatic Cancer GlobalData

View alBromodomain Testis Specific ProteinenCancerpCancer Research HorizonsView all

Twist will obtain a library access fee and will be eligible for annual maintenance fees. It will also receive a portion of the revenue generated from any assets sold or transferred.

Cancer Research Horizons TheVilamakitugnovaPancreatic Canceryder stated: “We’re delighted to partner with Twist Bioscience, an exciting technology platform company that will enhance our antibody discovery capabilities with their highly diverse phage display libraries.

“We look forward to using this technology to acceleCancerhe delivery of high-quality therapeutics and diagnostics to cancer patients, in collaboration with our academic and industrial partners.”

Twistibrary of libraries is a collection of synthesised antibody libraries, designed using naturally occurring sequences and incorporating innovative structural and developability features to encompass a range of antibody drug targets.

CancerBioscience CEO and co-founder Emily Leproust stated: “Cancer Research Horizons acts as a conduit betTwist Bioscienced industry, with our collaboration enabling early-stage antibody identification through access to our “library of libraries.”

“With two mission-driven organisations aligning behind innovative technology solutions to improve health to make the cancera better place, the opportunity to identify new biotherapeutics offers tremendous hope to those who need it most.”

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构